SOLA
LIVE

Serial Number

97394555

Owner

Sola Diagnostics GmbH

Attorney

John Mueller

Filing Date

May 4, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SOLA Trademark

Serial Number: 97394555

SOLA is a trademark filed by Sola Diagnostics GmbH on May 4, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Sola Diagnostics GmbH (2 trademarks)

Hauptplatz 4
Zams 6511 , AT

Entity Type: 99

Trademark Details

Filing Date

May 4, 2022

Registration Date

Not Registered

Goods & Services

Scientific research for chemical, biochemical, biological or bacteriological purposes; scientific research for medical purposes; scientific and medical research services; electronic data storage services; scientific and technological services and research and design relating thereto, namely, dna analysis services for scientific research purposes, scientific research consulting in the field of genetics; laboratory analysis in the field of chemistry; laboratory testing services in connection with the testing of bodily fluids, bodily tissue and blood for use in disease detection, namely, gynecological cancer and, in particular, cervical, uterine, ovarian and breast cancers ;development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research and analysis of data generated by scientific and medical experiments and tests being data for the diagnosis of disease, detection and identification of pathogens, for the detection of acquired or inherited genetic mutations and detection and analysis of epigenetic alterations, analysis of response to therapy; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of the diagnosis of disease, detection and identification of pathogens, for the detection of acquired or inherited genetic mutations, and for detection and analysis of epigenetic alterations; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer; consultancy, advisory and information services relating to research and development in the field of cancer diagnosis and detection

Diagnostic biomarker reagents for medical purposes used in connection with a cervical swab to identify gynaecologic cancers of the cervix, uterine body, ovary and breast; diagnostic kits comprised of medical assays for testing bodily fluids, bodily tissue and blood for use in disease detection, namely, gynecological cancer and, in particular, cervical, uterine, ovarian and breast cancers; diagnostic reagents in kit form for conducting assays for medical purposes; medical in vitro diagnostic reagents for polymerase chain reaction (pcr) technologies; medical diagnostic reagents; epigenetic test kits comprising reagents for testing and analysing bodily fluids, bodily tissue and blood for the diagnosis and detection of cancer; reagents and kits of reagents for preparing molecules, devices, consumables, and instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research, medical research, and medical diagnostic use

Medical apparatus for diagnostic testing of biological samples, namely, bodily fluids, body tissues and blood for the detection of cancer and disease; medical diagnostic apparatus for use in analytical tests for detecting cancer and disease from sample bodily fluids, bodily tissue and blood; instruments for making cervical smears; clinical diagnosis apparatus, namely, assays for testing of dna and epigenetics tests; dna and epigenetics testing apparatus for medical use; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of disease, detection and identification of pathogens, for the detection of acquired and inherited genetic mutations, detection and analysis of epigenetic alterations in relation to gynecological cancers of the cervix, uterine body, ovary and breast

Medical diagnostic services; medical testing services; medical diagnostic testing relating to the human body; blood testing services; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular testing and analysis services and DNA/RNA sequencing services for medical purposes; information, consultation and advisory services relating to medical diagnostic apparatus, instruments, preparations, products and testing; all of the foregoing for medical and research professionals and expressly excluding information in the fields of health and wellness

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 27, 2026 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 27, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 28, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 27, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 20, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 20, 2025 RCCK
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 5, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 5, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 5, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 5, 2025 REAP
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 19, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 16, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 19, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 19, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jul 19, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2023 CRFA
ASSIGNED TO LIE
Jul 18, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 14, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 14, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 14, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2022 NWOS
NEW APPLICATION ENTERED
May 7, 2022 NWAP